P
AHCO icon

&Partners’s AdaptHealth AHCO Stock Holding History

&Partners’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$631K Buy
53,004
+8,462
+19% +$86.6K ﹤0.01% 1565
2025
Q4 		$444K Buy
44,542
+568
+1% +$5.42K ﹤0.01% 1687
2025
Q3 		$394K Buy
43,974
+107
+0.2% +$991 ﹤0.01% 1598
2025
Q2 		$414K Buy
+43,867
New +$387K ﹤0.01% 1445

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

&Partners's AHCO Position: Q1 2026 in Review

&Partners increased its AdaptHealth (AHCO) stake by 19% in Q1 2026, buying an estimated $86.6K and bringing the position to 53,004 shares worth $631K. The position accounts for ﹤0.01% of the portfolio, ranked #1565.

&Partners first reported a position in AHCO in Q2 2025 and has held it in 4 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • &Partners held 53,004 shares of AdaptHealth worth $631K as of Q1 2026.
  • &Partners bought 8,462 AdaptHealth shares in Q1 2026, an estimated $86.6K.
  • AdaptHealth made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1565 holding.
  • &Partners first reported a position in AdaptHealth in Q2 2025 and has held it in 4 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.